| Original language | English |
|---|---|
| Pages (from-to) | 571-583 |
| Number of pages | 13 |
| Journal | Eur. Child Adolesc. Psychiatry |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2019 |
Keywords
- Attention-deficit/hyperactivity disorder (ADHD)
- Behavior
- Cognition
- Docosahexaenoic acid (DHA)
- Fatty acids
- docosahexaenoic acid
- placebo
- adolescent
- Article
- attention deficit disorder
- behavior
- behavior assessment
- child
- clinical article
- cognition
- controlled study
- diet supplementation
- fatty acid blood level
- female
- human
- male
- patient compliance
- quality of life
- randomized controlled trial
- rating scale
- social psychology
- attention
- child behavior
- child parent relation
- dietary supplement
- double blind procedure
- drug effect
- physiology
- psychology
- treatment outcome
- Adolescent
- Attention
- Attention Deficit Disorder with Hyperactivity
- Child
- Child Behavior
- Dietary Supplements
- Docosahexaenoic Acids
- Double-Blind Method
- Female
- Humans
- Male
- Parents
- Quality of Life
- Treatment Outcome
Cite this
Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial : European Child and Adolescent Psychiatry. / Crippa, A.; Tesei, A.; Sangiorgio, F.; Salandi, A.; Trabattoni, S.; Grazioli, S.; Agostoni, C.; Molteni, M.; Nobile, M.
In: Eur. Child Adolesc. Psychiatry, Vol. 28, No. 4, 2019, p. 571-583.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial
T2 - European Child and Adolescent Psychiatry
AU - Crippa, A.
AU - Tesei, A.
AU - Sangiorgio, F.
AU - Salandi, A.
AU - Trabattoni, S.
AU - Grazioli, S.
AU - Agostoni, C.
AU - Molteni, M.
AU - Nobile, M.
N1 - Export Date: 7 November 2019 CODEN: EAPSE Correspondence Address: Crippa, A.; Scientific Institute, IRCCS E. Medea, Child Psychopathology UnitItaly; email: alessandro.crippa@lanostrafamiglia.it
PY - 2019
Y1 - 2019
KW - Attention-deficit/hyperactivity disorder (ADHD)
KW - Behavior
KW - Cognition
KW - Docosahexaenoic acid (DHA)
KW - Fatty acids
KW - docosahexaenoic acid
KW - placebo
KW - adolescent
KW - Article
KW - attention deficit disorder
KW - behavior
KW - behavior assessment
KW - child
KW - clinical article
KW - cognition
KW - controlled study
KW - diet supplementation
KW - fatty acid blood level
KW - female
KW - human
KW - male
KW - patient compliance
KW - quality of life
KW - randomized controlled trial
KW - rating scale
KW - social psychology
KW - attention
KW - child behavior
KW - child parent relation
KW - dietary supplement
KW - double blind procedure
KW - drug effect
KW - physiology
KW - psychology
KW - treatment outcome
KW - Adolescent
KW - Attention
KW - Attention Deficit Disorder with Hyperactivity
KW - Child
KW - Child Behavior
KW - Dietary Supplements
KW - Docosahexaenoic Acids
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Male
KW - Parents
KW - Quality of Life
KW - Treatment Outcome
U2 - 10.1007/s00787-018-1223-z
DO - 10.1007/s00787-018-1223-z
M3 - Article
VL - 28
SP - 571
EP - 583
JO - Eur. Child Adolesc. Psychiatry
JF - Eur. Child Adolesc. Psychiatry
SN - 1018-8827
IS - 4
ER -